Default object view. Click to create a custom template, Node ID: 139209, Object ID: 82277

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast...

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer

Tags: Locally advanced Locally advanced , Metastatic Metastatic

No relation

Yes

No relation

No

06/06/2016 2:44 pm

No